We attempted to elucidate the hepatoprotective mechanism of two asiatic acid (AS) derivatives, 3β,23-dihydroxyurs-2-oxo-12ene-28-oic acid (AS-10) and 3β,23-dihydroxyurs-12-ene-28-oic acid (AS-14), which exhibited significant protective activity against carbon tetrachloride (CCl 4 )-induced hepatotoxicity in primary cultures of rat hepatocytes. Our findings showed that AS-10 and AS-14 preserved the level of glutathione and the activities of antioxidant enzymes such as glutathione reductase, glutathione peroxidase, superoxide dismutase and catalase. In addition, these compounds ameliorated lipid peroxidation, as demonstrated by a reduction in the production of malondialdehyde. Furthermore, AS-10 and AS-14 did not restore the reduced total GSH level by BSO, indicating that the hepatoprotective activities of these compounds may be involved, in part, by regulating GSH synthesis. From these results, we suggest that both AS-10 and AS-14 exerted their hepatoprotective activities against CCl 4 -induced injury by preserving the cellular antioxidative defense system.
Asiatic acid (AS) is one of the principal triterpenoids found in Centella asiatica (Umbelliferae), which has been used as a wound healing agent and tonic for the mentally retarded [1] . Triterpenoids exist widely in nature [2a] and exert such biological effects as hepatoprotective, anti-inflammatory, anti-hyperlipidemic, anti-ulcerative, and immunomodulatory, as well as having a prevention effect on skin tumors [2] .
In a previous study, we prepared several AS derivatives by modification of functional groups of AS to attain new candidates for the treatment of liver damage [3a] . As a result, we obtained 12 derivatives of AS and elucidated the relationship between their structures and hepato-protective activity [3a] . Among these AS derivatives, 3β,23-dihydroxyurs-2-oxo-12ene-28-oic acid (AS-10) and 3β,23-dihydroxyurs-12ene-28-oic acid , which differ only in the functional group at the C-2 position (Figure 1) , showed significant protective activities against carbon tetrachloride (CCl 4 )-induced toxicity in primary cultures of rat hepatocytes. Thus, the present study was undertaken to investigate the hepatoprotective mechanism of these AS derivatives, AS-10 and AS-14, against CCl 4 -induced toxicity in primary cultures of rat hepatocytes.
The hepatotoxic effect of CCl 4 is attributed to its metabolism by the cytochrome P450-monooxygenase system to form toxic trichloromethyl radicals and other reactive oxygen species that can act as free radical initiators [3b]. These radicals are known to interact with membrane lipids, thereby causing either lipid peroxidation or binding covalently to biological molecules, leading to hepatocellular membrane damage and disturbance of the cellular antioxidative defense system [3c,4] . To elucidate the hepatoprotective mechanisms of AS-10 and AS-14, first we determined their effects on the level of glutathione (GSH). Several lines of evidence indicated that CCl 4 -induced hepatotoxicity was associated with impairment of the cellular status of GSH in hepatocytes, and that protection against hepatotoxicity could be afforded by preserving cellular GSH status [5a-5c] . GSH, a ubiquitous tripeptide, is present in large concentrations in the liver. GSH plays a role in the elimination of a large number of nucleophilic exogenous toxicants by forming conjugates spontaneously or by being catalyzed by glutathione-S-transferase (GST) [5d].
Since the maintenance of cellular GSH is crucial for the endogenous cellular antioxidative defense system, the regeneration of GSH from oxidized glutathione (GSSG) may play an important role in any protection against free radical-mediated damage induced by CCl 4 [5c]. As shown in Table 1 , treatment of hepatocytes with either AS-10 or AS-14 at a concentration of 50 μM, significantly preserved the level of total GSH (GSH+GSSG), prevented the decrease of GSH level caused by CCl 4 (thereby increasing the cellular redox status index), and rescued the GSH/GSSG ratio, which was severely decreased in CCl 4 -injured hepatocytes. Treatment with AS-10, especially, preserved the total GSH level in CCl 4 -injured hepatocytes and thereby maintained the GSH/GSSG ratio almost to the control level.
GSH metabolism is also important in quenching the reactive intermediates and radical species generated during oxidative toxicity. Glutathione reductase (GR) is necessary for maintaining the cellular homeostasis of GSH [5c]. GST is known to play a pivotal role in detoxification [5d]. In addition, enzymes such as glutathione peroxidase (GPx), catalase and superoxide dismutase (SOD) play important roles in protecting against free radical damage [5d,5e]. As shown in Table 2 , AS-10, at a concentration of 50 μM, significantly preserved not only the activity of GR, which directly involves the turnover of GSH, but also the activities of GPx, SOD and catalase. By contrast, at a concentration of 50 μM, AS-14 did not significantly preserve GPx activity although it significantly preserved the activities of other antioxidative enzymes, such as GR and SOD. In addition, AS-10 and AS-14 had virtually no effect on the activity of GST (data not shown). Decrease in GSH content in CCl 4 -injured hepatocytes ultimately leads to lipid peroxidation followed by the death of the hepatocytes. AS-10 and AS-14, respectively, significantly prevented the production of malondialdehyde (MDA), a byproduct of lipid peroxidation in CCl 4 -injured hepatocytes ( Table 2) . These results suggest that the hepatoprotective activities of these AS derivatives may be due, at least in part, to maintenance of GSH level via collaborative actions of both antioxidant enzymes and a promotion of the recycling of GSH from GSSG catalyzed by GR.
We further investigated the effects of AS-10 and AS-14 on GSH biosynthesis using L-buthionine-S,Rsulfoximine (BSO), which leads to GSH depletion. BSO is a selective and irreversible inhibitor of γglutamylcysteine synthetase (γ-GCS), an enzyme that catalyzes the first step in GSH biosynthesis [5f,5g]. The incubation of hepatocytes with 1 mM BSO for 2 h caused a progressive depletion of total GSH (70.2 ±1.5 nmol/mg protein of control; 38.3 ±1.3 nmol/mg protein of BSO-treated hepatocytes). Treatment with AS-10 or AS-14 did not restore the reduced total GSH level by BSO although the data showed statistical significance (Table 3 ). These results suggested that these AS derivatives may affect total GSH level by, in part, regulating hepatic γ-GCS activity.
Taken together, the results demonstrated that the hepatoprotective activities of both AS-10 and AS-14 against CCl 4 -toxicity may be due, in part, to preserveing the cellular antioxidant system and Primary cultured rat hepatocytes were exposed to 5 mM CCl 4 with or without AS-10 or AS-14. AS-10, AS-14 and silybin were administered at a concentration of 50 μM, respectively. Activity of each enzyme was measured as described in Experimental. Values given represent the mean ± S.D. for three separate experiments. GR, and GPx; μmol NADPH consumed/min/mg protein, respectively; Catalase: μmol H 2 O 2 consumed/min/mg protein; SOD: units/ml; MDA: nmol/mg protein. Value differs significantly from the value of CCl 4 -treated: * p < 0.05, ** p < 0.01, *** p < 0.001. thereby ameliorating lipid peroxidation. In addition, considering the chemical structures of AS-10 and AS-14, the existence of a carbonyl group at the C-2 position of AS derivatives seems to be important for preserving the level of GSH and activity of GPx, as well as for protecting primary cultures of rat hepatocytes from CCl 4 -induced injury. The present study suggests that AS derivatives like AS-10 and AS-14 may have a potential to be developed as therapeutic agents to treat liver damage, even though it is necessary to investigate further whether AS derivatives exert hepatoprotective effects in vivo, for example, in animal models of liver damage, to explore its therapeutic potentials.
Experimental

Animals: Male Wistar rats (200-250 g body weight)
were provided by the Laboratory Animal Center, Seoul National University. They were kept on standard rat chow with free access to tap water in temperature-and humidity-controlled animal quarters under a 12-h light-dark cycle. All experiments were conducted according to the guidelines of the Committee on Care and Use of Laboratory Animals of Seoul National University.
Materials: AS-10 and AS-14 were prepared by chemical modification at the C-2 position according to the methods previously described [3a] . Waymouth's MB 752/1 medium, bovine serum albumin (fraction V), dexamethasone, insulin, L-alanine, L-serine, sodium bicarbonate, penicillin/streptomycin, gentamycin sulfate, Hank's balanced salt solution, urethane, dimethyl sulfoxide (DMSO), trypan blue, collagenase (type IV), thiobarbituric acid and other reagents used for the evaluation of enzyme activities were obtained from Sigma (St. Louis, MO, USA).
Isolation and culture of rat hepatocytes:
Isolated hepatocytes were prepared from male Wistar rats by the collagenase perfusion technique, as described previously [6a] . Cells were purified by serial centrifugations and inoculated on to culture dishes at a density of 5 x 10 5 cells/mL. One day after the isolated rat hepatocytes had been plated, the cultured cells were exposed to a medium containing 5 mM CCl 4 /ethanol (final concentration, 0.07%) for 1.5 h to induce hepatotoxicity [5a,6b] . Some cultured cells were also exposed to a medium containing 1 mM BSO, an inhibitor of γ-GCS, for 2 h to reduce the cellular level of GSH [6c].
Treatments with AS-10 or AS-14: AS-10 and AS-14 were dissolved in DMSO (final concentration, 0.1%). One day after plating isolated rat hepatocytes, the cultured cells were exposed to a culture medium containing 5 mM CCl 4 either with or without AS-10 or AS-14. One and a half hours after the CCl 4 challenge, the culture medium was removed. The cells were harvested to determine the activities of various antioxidant enzymes as well as the levels of MDA and GSH. Some hepatocytes were exposed to 1 mM BSO for 2 h. After the BSO containing medium was aspirated, the cells were incubated with or without AS-10 or AS-14 for an additional 1 h. The harvested cells were used for determining the level of GSH.
Determination of antioxidant enzyme activity:
Microsomal fractions were prepared from the cultured rat hepatocytes, as described elsewhere [7a] . SOD activity was determined according to the method of McCord and Fridovich [7b] , using the xanthine-xanthine oxidase reaction. Catalase activity was determined according to the method of Beers and Sizer based on H 2 O 2 decomposition [7c]. GR activity, based on the reduction of GSSG by GR and β-nicotinamide adenine dinucleotide phosphate (NADPH), was measured according to the method of Carlberg and Mannervik [7d]. GPx activity was determined by measuring the rate of oxidation of GSH to GSSG by cumene hydroperoxide, a reaction catalyzed by GPx [7e]. GST activity was determined spectrophotometrically by measuring the rate of formation of the GSH and 1-chloro-2,4dinitrobenzene conjugate, according to the method of Habig et al. [7f] .
Determination of the levels of GSH and MDA:
The level of GSH was determined spectrophotometrically using the enzymatic cycling method of Tietz [8a] , with minor modification. The level of MDA was determined by the thiobarbituric acid method [8b].
Protein assay and Statistical analysis:
The protein content was measured by the method of Lowry et al.
[8c] with bovine serum albumin as a standard. All data are expressed as the mean ± SD. The evaluation of statistical significance was determined by "the one-way ANOVA" test.
